190 related articles for article (PubMed ID: 29261513)
1. High-content hydrogen water-induced downregulation of miR-136 alleviates non-alcoholic fatty liver disease by regulating Nrf2 via targeting MEG3.
Wang X; Wang J
Biol Chem; 2018 Mar; 399(4):397-406. PubMed ID: 29261513
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting miR-27a and miR-142-5p attenuate nonalcoholic fatty liver disease by regulating Nrf2 signaling pathway.
Teimouri M; Hosseini H; Shabani M; Koushki M; Noorbakhsh F; Meshkani R
IUBMB Life; 2020 Mar; 72(3):361-372. PubMed ID: 31889412
[TBL] [Abstract][Full Text] [Related]
3. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease.
Liu J; Tang T; Wang GD; Liu B
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31064820
[No Abstract] [Full Text] [Related]
4. The mechanism of long non-coding RNA MEG3 for hepatic ischemia-reperfusion: Mediated by miR-34a/Nrf2 signaling pathway.
Huang X; Gao Y; Qin J; Lu S
J Cell Biochem; 2018 Jan; 119(1):1163-1172. PubMed ID: 28708282
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MEG3 functions as a ceRNA in regulating hepatic lipogenesis by competitively binding to miR-21 with LRP6.
Huang P; Huang FZ; Liu HZ; Zhang TY; Yang MS; Sun CZ
Metabolism; 2019 May; 94():1-8. PubMed ID: 30711569
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2.
Chen X; Ma H; Gao Y; Jin Y; Ning W; Hou Y; Su J
Bioengineered; 2021 Dec; 12(1):6738-6747. PubMed ID: 34511037
[TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA MEG3 Inhibits Apoptosis of Retinal Pigment Epithelium Cells Induced by High Glucose via the miR-93/Nrf2 Axis.
Luo R; Jin H; Li L; Hu YX; Xiao F
Am J Pathol; 2020 Sep; 190(9):1813-1822. PubMed ID: 32473920
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA GAS5 contributes to the progression of nonalcoholic fatty liver disease by targeting the microRNA-29a-3p/NOTCH2 axis.
Cui J; Wang Y; Xue H
Bioengineered; 2022 Apr; 13(4):8370-8381. PubMed ID: 35322757
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
[TBL] [Abstract][Full Text] [Related]
10. Icariin alleviates high-fat diet-induced nonalcoholic fatty liver disease via up-regulating miR-206 to mediate NF-κB and MAPK pathways.
Zhao H; Tian H
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23566. PubMed ID: 37888945
[TBL] [Abstract][Full Text] [Related]
11. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
Fu D; Cui H; Zhang Y
Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
[TBL] [Abstract][Full Text] [Related]
12. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
Long JK; Dai W; Zheng YW; Zhao SP
Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
[TBL] [Abstract][Full Text] [Related]
13. LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease.
Chen X; Tan XR; Li SJ; Zhang XX
Life Sci; 2019 Oct; 235():116829. PubMed ID: 31484042
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease.
Xu M; Zheng XM; Jiang F; Qiu WQ
J Cell Biochem; 2018 Jul; 119(7):5864-5874. PubMed ID: 29575055
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-205 ameliorates lipid accumulation in non-alcoholic fatty liver disease through targeting NEU1.
Hu Y; Ye H; Shi LX
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):10072-10082. PubMed ID: 31799678
[TBL] [Abstract][Full Text] [Related]
16. Gan-Jiang-Ling-Zhu decoction alleviates hepatic steatosis in rats by the miR-138-5p/CPT1B axis.
Dang Y; Xu J; Zhu M; Zhou W; Zhang L; Ji G
Biomed Pharmacother; 2020 Jul; 127():110127. PubMed ID: 32325349
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-376b-3p ameliorates nonalcoholic fatty liver disease by targeting FGFR1 and regulating lipid oxidation in hepatocytes.
Wang XY; Lu LJ; Li YM; Xu CF
Life Sci; 2022 Nov; 308():120925. PubMed ID: 36057399
[TBL] [Abstract][Full Text] [Related]
18. Sodium butyrate ameliorates non-alcoholic fatty liver disease by upregulating miR-150 to suppress CXCR4 expression.
Zhang N; Qu Y; Qin B
Clin Exp Pharmacol Physiol; 2021 Aug; 48(8):1125-1136. PubMed ID: 33721354
[TBL] [Abstract][Full Text] [Related]
19. [Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis].
Cai YQ; Zhang LZ; Wang DJ; Chen FM; Chen ZY; Zhu KY; Li JS; Yan MX
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Sep; 30(5):465-70. PubMed ID: 25571645
[TBL] [Abstract][Full Text] [Related]
20. Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway.
Huang Y; Huang L; Zhu G; Pei Z; Zhang W
J Cell Physiol; 2019 May; 234(5):6023-6032. PubMed ID: 30584668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
